Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas Southwestern Medical Center
Investigators aim to perform a prospective study of anti-18F-FACBC PET/CT in patients with NSGCT prior to RPLND, either in the primary setting or in the post-chemotherapy setting. We will correlate histopathologic outcomes from the RPLND specimen and clinical outcomes of recurrence during follow-up to identify the accuracy of anti-18F-FACBC PET/CT in these settings.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with histologically confirmed NSGCT after orchiectomy who are scheduled to undergo primary RPLND or post-chemotherapy RPLND
Patients must be over 18 years old and capable and willing to provide informed consent.
Medically stable as judged by patient's physician.
Life expectancy must be estimated at \> 6 months.
Patients must have an ECOG performance status of 0-3 (restricted to ECOG PS 0-2 if age \>70 years).
Patient must be able to lie still for a 20 to 30 minute PET/CT scan. Patients will be asked if they have problems or issues with lying flat
Clareo Health | Role of Axumin PET Scan in Germ Cell Tumor
